Listen: HHS Files Challenge Over Rights To Gilead’s HIV-Prevention Drug
KHN's Shefali Luthra discusses the recent Trump administration lawsuit regarding the HIV-prevention drug Truvada.
Search
Filter
Clear All241-260 of 659 results
-
-
Labs With No One to Run Them: Why Public Health Workers Are Fleeing the Field
Across California, public health departments are losing experienced staffers to exhaustion, partisan politics and jobs that pay more for less work. The public health nurses, epidemiologists and microbiologists who work to keep our communities healthy are abandoning the field.
-
Needle Exchanges Are Targeted by Eco-Rooted Lawsuits. A New California Law Will Stop That.
Opponents of free needle programs in California are using environmental regulations to shut them down. On Monday, Gov. Gavin Newsom signed a bill that will end that strategy.
By Rachel Bluth -
A Daily Pill to Treat Covid Could Be Just Months Away, Scientists Say
At least three promising antiviral treatments for covid-19 are being tested in clinical trials, with results expected as soon as late fall or winter.
-
Biden Releases a New Plan to Combat Covid, but Experts Say There’s Still a Ways to Go
There’s agreement that the plan includes important action items but also elements that will trigger political opposition.
By Victoria Knight and Julie Appleby -
What It Means When Celebrities Stay Coy About Their Vaccine Status
St. Louis Blues leading scorer David Perron took 10 days to explain he had indeed been vaccinated before he caught covid-19, which knocked him from playing in the NHL playoffs against the Colorado Avalanche. His case and those of other public figures raise questions about the role of celebrity in enticing people to get covid vaccinations.
By Eric Berger -
The WHO Didn’t Reverse Its Position on Kids and Covid Vaccines
The World Health Organization this week updated its guidance on children and covid vaccinations — but in a different way than alleged in a viral social media post.
-
‘I Don’t Want to Risk My Life for a Paycheck’: Immunosuppressed People Grapple With Returning to Work
Millions of Americans with weakened immune systems are weighing a return to workplaces as the delta variant of covid surges and while awaiting guidance about additional vaccine shots.
-
Commentary
Why We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
It could take years for follow-up studies to prove Aduhelm slows the disease — or doesn’t. Meanwhile, its maker will profit.
-
Syphilis Cases in California Drive a Record-Setting Year for STDs Nationwide
New data released Tuesday from the CDC shows sexually transmitted infections reached an all-time high in 2019. The biggest spike was in syphilis cases, which rose 74% between 2015 and 2019. Leading the country in syphilis is California, where men who have sex with men make up half the cases.
-
‘Injections, Injections, Injections’: Troubling Questions Follow Closure of Sprawling Pain Clinic Chain
In May 2021, Lags Medical Centers, one of California’s largest chains of pain clinics, abruptly closed its doors amid a cloaked state investigation. Nine months later, patients are still in the dark about what happened with their care and to their bodies.
-
Journalists Explore Breast Cancer Rates and the Medical Response to Mass Shootings
KFF Health News and California Healthline journalists made the rounds on local and state media recently to discuss topical stories. Here’s a collection of their appearances.
-
Over Half of States Have Rolled Back Public Health Powers in Pandemic
At least 26 states have passed laws to permanently limit public health powers, a KHN investigation has found, weakening the country’s ability to fight not only the current resurgence of the pandemic but other health crises to come.
-
Analysis: Why We’ll Likely Never Know Whether a Covid Lab Leak Happened in China
If international scientific sleuths are hoping to see a lab log or find a whistleblower, that sort of information won’t be revealed. In China today, it is dangerous to say what you know if it challenges the official government narrative.
-
Unraveling the Mysterious Mutations That Make Delta the Most Transmissible Covid Virus Yet
Scientists are trying to piece together why the delta variant so readily infects unvaccinated Americans, spewing 1,000 times more virus particles.
By Liz Szabo -
Dying Patients With Rare Diseases Struggle to Get Experimental Therapies
When patients with common terminal illnesses such as cancer seek permission for compassionate use of therapies in the testing stage, their requests often are approved. But those with more unusual illnesses say drug companies are rarely willing to provide access.
-
California Lawmakers Push Feds to Allow a Therapy That Pays Meth Users to Abstain
The approach, known as contingency management, has helped thousands of veterans kick the methedrine habit, but a federal government ruling has limited its use. California hopes to challenge that and make the treatment a Medi-Cal benefit.
-
‘Incredibly Concerning’ Lawsuit Threatens No-Charge Preventive Care for Millions
A Texas federal judge, who previously ruled the Affordable Care Act unconstitutional, has signaled his openness to ending the law’s popular coverage requirement for preventive services.
By Harris Meyer -
New Protocol For HIV Prevention Drug Reduces The Number Of Pills Required
Health officials and AIDS advocates in San Francisco have endorsed a new regimen for PrEP medication: to be taken only immediately before and after sex, thus reducing cost and potential side effects. The standard regimen is one pill a day for an open-ended period.
By David Tuller -
Commentary
Telemedicine Is a Tool — Not a Replacement for Your Doctor’s Touch
The pandemic has demonstrated that virtual medicine is great for simple visits. But many new types of telemedicine promoted by start-ups more clearly benefit providers’ and investors’ pockets, rather than yielding more convenient, high-quality and cost-effective medicine for patients.